Establishment of an integration-free human induced pluripotent stem cell line (TJCi001-A) from normal bone marrow-derived mesenchymal stem cells
Summary
Bone marrow-derived mesenchymal stem cells (BM-MSCs) possess excellent therapeutic potential for the treatment of various diseases including graft-versus-host disease, rheumatoid arthritis, osteoarthritis, and multiple sclerosis. Here, we generated an induced pluripotent stem cell (iPSC) line from BM-MSCs employing a non-integrating episomal vector. The generated iPSCs expressed pluripotency markers, showed a normal karyotype, and exhibited the potential for in vitro differentiation into three germ layers. This iPSC line can be used as a healthy control in stem cell therapeutics and disease modeling studies. Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.
| Authors | Choi NY, Lee Y, Park YS, Ko K, Park B, Koh YG |
|---|---|
| Journal | Stem cell research |
| Publication Date | 2021 Aug;55:102484 |
| PubMed | 34371346 |
| DOI | 10.1016/j.scr.2021.102484 |